Eden Research (LON:EDEN) Trading Down 0.2% – What’s Next?

Eden Research plc (LON:EDEN)’s stock price was down 0.2% on Friday . The company traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). Approximately 10,000 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 0.2 %

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The company has a market capitalization of £19.17 million, a P/E ratio of -12.59 and a beta of 0.92. The company’s fifty day simple moving average is GBX 3.88 and its 200-day simple moving average is GBX 3.95.

Insider Activity

In other news, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). Also, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.